Nj State Employees Deferred Compensation Plan Theravance Biopharma, Inc. Transaction History
Nj State Employees Deferred Compensation Plan
- $761 Million
- Q1 2025
A detailed history of Nj State Employees Deferred Compensation Plan transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Nj State Employees Deferred Compensation Plan holds 58,142 shares of TBPH stock, worth $625,026. This represents 0.07% of its overall portfolio holdings.
Number of Shares
58,142
Previous 58,142
-0.0%
Holding current value
$625,026
Previous $547,000
5.12%
% of portfolio
0.07%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding TBPH
# of Institutions
136Shares Held
47.3MCall Options Held
700Put Options Held
1.4K-
Madison Avenue Partners, LP New York, NY9.51MShares$102 Million10.97% of portfolio
-
Weiss Asset Management LP Boston, MA7.46MShares$80.2 Million1.9% of portfolio
-
Newtyn Management, LLC New York, NY4.76MShares$51.1 Million8.37% of portfolio
-
Black Rock Inc. New York, NY3.78MShares$40.6 Million0.0% of portfolio
-
Irenic Capital Management LP New York, NY2.76MShares$29.7 Million3.74% of portfolio
About Theravance Biopharma, Inc.
- Ticker TBPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,782,400
- Market Cap $718M
- Description
- Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...